Large-scale testing (Phase 3)Study completedNCT01871428
What this trial is testing
Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy
Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 13